Influence of residual blood autotransfused from cardiopulmonary bypass circuit on clinical outcome after cardiac surgery

Abstract

Autotransfusion of the residual blood from the cardio-pulmonary bypass (CPB) circuit is considered to be one of the methods enabling reduction in the need for transfusion, the possible adverse effects of which are well known and documented. The aim of the study was to evaluate the effectiveness of the autologous autotrans-fusion of centrifuged red blood cells from the residual blood of the CPB circuit in patients following heart surgery.

Three groups of patients who underwent heart surgery were examined. The first group (Group 1) consisted of 37 patients who received all of the residual blood in the bypass circuit after CPB (collected into sterile plastic bags) during the early postoperative period. The second group (Group 2) consisted of 45 patients who did not receive the residual blood following CPB. The third group (Group 3) consisted of 42 patients who underwent re-infusion of centrifuged red blood cells from the residual blood remaining in the CPB circuit during the early postoperative period.

Hematocrit (Hct) values 12 hours after the operation were found to be higher in Group 3 compared with those of the first and the second groups (by 13.2% and 11.1%, respectively). Blood loss during the first 12 hours after the operation and during the time spent in the intensive care unit did not differ between the groups. The number of transfusions was significantly lower in Group 3 (28.57%) in comparison with that of Groups 1 and 2 (37.83% and 38.10%, respectively). The rate of infective complications in Group 3 was lower in comparison with both Group 1 and Group 2 (9.2% and 18.1%, respectively). The duration of in-hospital stay in Group 3 was 25.8% shorter than Group 1.

We conclude that autotransfusion of centrifuged red blood cells processed from the residual blood of the CPB circuit after CPB was effective in increasing Hct values 12 hours postoperatively, reducing the need for donor blood product transfusions, the rate of infective complications and lenght of stay in hospital.

Get full access to this article

View all access options for this article.

References

Dalrymple-Hay MJ , Dawkins S , Pack L et al. Auto-transfusion decreases blood usage following cardiac surgery-a prospective randomized trial . Cardiovasc Surg 2001; 9: 184-187 .

Tempe DK , Banerjee A , Virmani S et al. Comparison of the effects of a cell saver and low-dose aprotinin on blood loss and homologous blood usage in patients undergoing valve surgery . J Cardiothorac Vasc Anesth 2001; 15: 326-330 .

Cross MH. Autotransfusion in cardiac surgery . Perfusion 2001; 16: 391-400 .

Ean AH , Yan TS , Chan T et al. Centrifugation of salvaged pump blood is useful in reducing the amount of heparin re-infused into the patient . Perfusion 2001; 16: 309-312 .

Amand T , Pincemail J , Blaffart F et al. Levels of inflammatory markers in the blood processed by autotransfusion devices during cardiac surgery associated with cardiopulmonary bypass circuit . Perfusion 2002; 17: 117-123 .

Walpoth BH , Eggensperger N , Hauser SP et al. Effects of unprocessed and processed cardiopulmonary bypass blood retransfused into patients after cardiac surgery . Int J Artif Organs 1999; 22: 210-216 .

Schmidt H , Bendtzen K , Mortensen PE. The inflammatory cytokine response after autotransfusion of shed mediastinal blood . Acta Anaesthesiol Scand 1998; 42: 558-564 .

Hardy JF , Belisle S , Janvier G. Reduction in requirements for allogenic blood products: nonpharmacologic methods . Ann Thorac Surg 1996; 62: 1935-1943 .

Svenmarker S , Engstrom KB. The inflammatory response to recycled pericardial suction blood and the influence of cell-saving . Scand Cardiovasc J 2003; 37: 158-164 .

10.

Jewell AE , Akowuah EF , Suvarna SK , Braidley P , Hopkinson D , Cooper G. A prospective randomized comparison of cardiotomy suction and cell saver for recycling shed blood during cardiac surgery . European Journal of Cardio-thoracic Surgery 2003; 23: 633-636 .

11.

Kincaid E , Jones T , Stump D et al. Processing of scavenged blood with cell saver reduces cerebral lipid microembolization . Ann Thorac Surg 1998; 65: 1651-1655 .

12.

Merville C , Charlet P , Zerr C , Bricard H. Effectiveness of the Cell Saver and salvage from ultrafiltered extra-corporeal circulation in heart surgery . Ann Fr Anesth Reanim 1991; 10: 548-553 .

13.

Daane CR , Golab HD , Meeder JH , Wijers MJ , Bogers AJ. Processing and transfusion of residual cardiopulmonary bypass volume: effects on haemostasis, complement activation, postoperative blood loss and transfusion volume . Perfusion 2003; 18: 115-121 .

14.

Levit AL , Buldakova TL , Shalin PV , et al. The efficacy of using blood-saving technologies in operations on the heart and aorta . Anesteziol Reanimatol 2000; 3: 21-23 .

15.

Zhao K , Xu J , Hu S , Wu Q , Wei Y , Liu Y. Autotransfusion of shed mediastinal blood after open heart surgery . Chin Med J (Engl.) 2003; 116: 1179-1182 .

16.

Ean AH , Yan TS , Chan T , James E , Chi OB. Centrifugation of salvaged pump blood is useful in reducing the amount of heparin re-infused into the patient . Perfusion 2001; 16: 309-312 .

17.

De Haan J , Boonstra PW , Monnink SHJ et al. Retrans-fusion of suctioned blood during cardiopulmonary bypass impairs haemostasis . Ann Thorac Surg 1995; 59: 901-907 .